1	Una	Una		C0205447_1	calificador_1	0-3	100_QUEST_clinical_caseMIR	SENT1	-	-
2	mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	4-9	100_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	10-12	100_QUEST_clinical_caseMIR	SENT1	-	-
4	43	43		-	-	13-15	100_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	16-20	100_QUEST_clinical_caseMIR	SENT1	-	-
6	consulta	consulta	NCFS000	C3543841#C0009818	metadato_fundacional#procedimiento	21-29	100_QUEST_clinical_caseMIR	SENT1	-	-
7	a	a	SPS00	-	-	30-31	100_QUEST_clinical_caseMIR	SENT1	-	-
8	su	su	DP3CS0	-	-	32-34	100_QUEST_clinical_caseMIR	SENT1	-	-
9	médico	médico	NCCS000	C0033131_1	ocupación_1	35-41	100_QUEST_clinical_caseMIR	SENT1	-	-
10	de	de	SPS00	C0033131_2	ocupación_2	42-44	100_QUEST_clinical_caseMIR	SENT1	-	-
11	Atención	atención	NCFS000	C0033131_3	ocupación_3	45-53	100_QUEST_clinical_caseMIR	SENT1	-	-
12	Primaria	primario	AQ0FS0	C0033131_4	ocupación_4	54-62	100_QUEST_clinical_caseMIR	SENT1	-	-
13	por	por	SPS00	C0678226	atributo	63-66	100_QUEST_clinical_caseMIR	SENT1	-	-
14	cansancio	cansancio	NCMS000	C0015672#C0475255	hallazgo#calificador	67-76	100_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	,	,	Fc	-	-	76-77	100_QUEST_clinical_caseMIR	SENT1	-	-
16	gingivorragia	gingivorragia	NCFS000	-	-	78-91	100_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
17	y	y	CC	C1706368	calificador	92-93	100_QUEST_clinical_caseMIR	SENT1	-	-
18	petequias	petequia	NCFP000	C0031256	anomalía_morfológica	94-103	100_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
19	.	.	Fp	-	-	103-104	100_QUEST_clinical_caseMIR	SENT1	-	-

1	Se	se	P00CN000	-	-	105-107	100_QUEST_clinical_caseMIR	SENT2	-	-
2	realiza	realizar	VMIP3S0	-	-	108-115	100_QUEST_clinical_caseMIR	SENT2	-	-
3	analítica	analítica	NCFS000	-	-	116-125	100_QUEST_clinical_caseMIR	SENT2	-	-
4	en	en	SPS00	C1720294#C0332285	calificador#atributo	126-128	100_QUEST_clinical_caseMIR	SENT2	-	-
5	la	el	DA0FS0	-	-	129-131	100_QUEST_clinical_caseMIR	SENT2	-	-
6	que	que	PR0CN000	-	-	132-135	100_QUEST_clinical_caseMIR	SENT2	-	-
7	destaca	destacar	VMIP3S0	-	-	136-143	100_QUEST_clinical_caseMIR	SENT2	-	-
8	:	:	Fd	-	-	143-144	100_QUEST_clinical_caseMIR	SENT2	-	-
9	anemia	anemia	NCFS000	C0002871#C0221395#C1510654	trastorno	145-151	100_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
10	de	de	SPS00	C0332285	atributo	152-154	100_QUEST_clinical_caseMIR	SENT2	-	-
11	8	8	Z	-	-	155-156	100_QUEST_clinical_caseMIR	SENT2	-	-
12	gr	g	NC00SC0	-	-	157-159	100_QUEST_clinical_caseMIR	SENT2	-	-
13	/	/	Fh	-	-	159-160	100_QUEST_clinical_caseMIR	SENT2	-	-
14	dl	decilitro	NCMN000	C0439241	calificador	160-162	100_QUEST_clinical_caseMIR	SENT2	-	-
15	,	,	Fc	-	-	162-163	100_QUEST_clinical_caseMIR	SENT2	-	-
16	trombopenia	trombopenia	NCFS000	C0040034_1	trastorno_1	164-175	100_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
17	de	de	SPS00	C0332285	atributo	176-178	100_QUEST_clinical_caseMIR	SENT2	-	-
18	4000/microlitro	4000/microlitro		-	-	179-194	100_QUEST_clinical_caseMIR	SENT2	-	-
19	y	y	CC	C1706368	calificador	195-196	100_QUEST_clinical_caseMIR	SENT2	-	-
20	leucopenia	leucopenia	NCFS000	C0023530#C0750394	trastorno#hallazgo	197-207	100_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
21	de	de	SPS00	C0332285	atributo	208-210	100_QUEST_clinical_caseMIR	SENT2	-	-
22	1200/microlitro	1200/microlitro		-	-	211-226	100_QUEST_clinical_caseMIR	SENT2	-	-
23	con	con	SPS00	C0332287	atributo	227-230	100_QUEST_clinical_caseMIR	SENT2	-	-
24	neutropenia	neutropenia	NCFS000	C0027947#C0001824#C1534864#C1576411#C0853697	trastorno#hallazgo	231-242	100_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
25	absoluta	absoluto	AQ0FS0	C0205344	calificador	243-251	100_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
26	.	.	Fp	-	-	251-252	100_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	253-255	100_QUEST_clinical_caseMIR	SENT3	-	-
2	estudio	estudio	NCMS000	C0557651	medio_ambiente	256-263	100_QUEST_clinical_caseMIR	SENT3	-	-
3	de	de	SPS00	C0332285	atributo	264-266	100_QUEST_clinical_caseMIR	SENT3	-	-
4	coagulación	coagulación	NCFS000	C0441509	procedimiento	267-278	100_QUEST_clinical_caseMIR	SENT3	-	-
5	se	se	P00CN000	-	-	279-281	100_QUEST_clinical_caseMIR	SENT3	-	-
6	observa	observar	VMIP3S0	-	-	282-289	100_QUEST_clinical_caseMIR	SENT3	-	-
7	alargamiento	alargamiento	NCMS000	C0441592	calificador	290-302	100_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
8	del	del	SP+DA	-	-	303-306	100_QUEST_clinical_caseMIR	SENT3	-	-
9	APTT	activated_partial_thromboplastin_time_(tiempo_de_tromboplastina_parcial_activada)	NC00YL0	-	-	307-311	100_QUEST_clinical_caseMIR	SENT3	-	-
10	(	(	Fpa	-	-	312-313	100_QUEST_clinical_caseMIR	SENT3	-	-
11	43	43		-	-	313-315	100_QUEST_clinical_caseMIR	SENT3	-	-
12	″	″	Fz	-	-	315-316	100_QUEST_clinical_caseMIR	SENT3	-	-
13	)	)	Fpt	-	-	316-317	100_QUEST_clinical_caseMIR	SENT3	-	-
14	,	,	Fc	-	-	317-318	100_QUEST_clinical_caseMIR	SENT3	-	-
15	actividad	actividad	NCFS000	C0441655	entidad_observable	319-328	100_QUEST_clinical_caseMIR	SENT3	-	-
16	de	de	SPS00	C0332285	atributo	329-331	100_QUEST_clinical_caseMIR	SENT3	-	-
17	la	el	DA0FS0	-	-	332-334	100_QUEST_clinical_caseMIR	SENT3	-	-
18	protrombina	protrombina	NCFS000	C0033706	sustancia	335-346	100_QUEST_clinical_caseMIR	SENT3	-	-
19	disminuida	disminuir	VMP00SF	-	-	347-357	100_QUEST_clinical_caseMIR	SENT3	-	-
20	(	(	Fpa	-	-	358-359	100_QUEST_clinical_caseMIR	SENT3	-	-
21	55	55	Z	-	-	359-361	100_QUEST_clinical_caseMIR	SENT3	-	-
22	%	%	Ft	-	-	361-362	100_QUEST_clinical_caseMIR	SENT3	-	-
23	)	)	Fpt	-	-	362-363	100_QUEST_clinical_caseMIR	SENT3	-	-
24	,	,	Fc	-	-	363-364	100_QUEST_clinical_caseMIR	SENT3	-	-
25	hipofibrinogenemia	hipofibrinogenemia	NCFS000	C0553681	trastorno	365-383	100_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
26	(	(	Fpa	-	-	384-385	100_QUEST_clinical_caseMIR	SENT3	-	-
27	98	98	Z	-	-	385-387	100_QUEST_clinical_caseMIR	SENT3	-	-
28	mg	mg	NCMN000	-	-	388-390	100_QUEST_clinical_caseMIR	SENT3	-	-
29	/	/	Fh	-	-	390-391	100_QUEST_clinical_caseMIR	SENT3	-	-
30	dl	decilitro	NCMN000	C0439241	calificador	391-393	100_QUEST_clinical_caseMIR	SENT3	-	-
31	)	)	Fpt	-	-	393-394	100_QUEST_clinical_caseMIR	SENT3	-	-
32	y	y	CC	C1706368	calificador	395-396	100_QUEST_clinical_caseMIR	SENT3	-	-
33	presencia	presenciar	VMM02S0	C0150312_1	calificador_1	397-406	100_QUEST_clinical_caseMIR	SENT3	-	-
34	de	de	SPS00	C0150312_2	calificador_2	407-409	100_QUEST_clinical_caseMIR	SENT3	-	-
35	concentración	concentración	NCFS000	C0086045	entidad_observable	410-423	100_QUEST_clinical_caseMIR	SENT3	-	-
36	elevada	elevar	VMP00SF	-	-	424-431	100_QUEST_clinical_caseMIR	SENT3	-	-
37	de	de	SPS00	C0332285	atributo	432-434	100_QUEST_clinical_caseMIR	SENT3	-	-
38	D-Dimero	d-dimero	RG	-	-	435-443	100_QUEST_clinical_caseMIR	SENT3	-	-
39	y	y	CC	C1706368	calificador	444-445	100_QUEST_clinical_caseMIR	SENT3	-	-
40	monómeros	monómero	NCMP000	-	-	446-455	100_QUEST_clinical_caseMIR	SENT3	-	-
41	de	de	SPS00	C0332285	atributo	456-458	100_QUEST_clinical_caseMIR	SENT3	-	-
42	fibrina	fibrina	NCFS000	C0015982	sustancia	459-466	100_QUEST_clinical_caseMIR	SENT3	-	-
43	.	.	Fp	-	-	466-467	100_QUEST_clinical_caseMIR	SENT3	-	-

1	Se	se	P00CN000	-	-	468-470	100_QUEST_clinical_caseMIR	SENT4	-	-
2	remite	remitir	VMIP3S0	C0439600	calificador	471-477	100_QUEST_clinical_caseMIR	SENT4	-	-
3	para	para	SPS00	C0521125	calificador	478-482	100_QUEST_clinical_caseMIR	SENT4	-	-
4	estudio	estudio	NCMS000	C0557651	medio_ambiente	483-490	100_QUEST_clinical_caseMIR	SENT4	-	-
5	hematológico	hematológico	AQ0MS0	C0205488	calificador	491-503	100_QUEST_clinical_caseMIR	SENT4	-	-
6	urgente	urgente	AQ0CS0	C0439609	calificador	504-511	100_QUEST_clinical_caseMIR	SENT4	-	-
7	,	,	Fc	-	-	511-512	100_QUEST_clinical_caseMIR	SENT4	-	-
8	realizando	realizar	VMG0000	-	-	513-523	100_QUEST_clinical_caseMIR	SENT4	-	-
9	se	se	PP3CN000	-	-	523-525	100_QUEST_clinical_caseMIR	SENT4	-	-
10	un	un		C0205447_1	calificador_1	526-528	100_QUEST_clinical_caseMIR	SENT4	-	-
11	aspirado	aspirado	NC00SC0	C0370199	espécimen	529-537	100_QUEST_clinical_caseMIR	SENT4	-	-
12	de	de	SPS00	C0332285	atributo	538-540	100_QUEST_clinical_caseMIR	SENT4	-	-
13	médula	médula	NCFS000	C0005953#C0229619_1	estructura_corporal_1	541-547	100_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
14	ósea	óseo	AQ0FS0	C0005953#C0229619_2	estructura_corporal_2	548-552	100_QUEST_clinical_caseMIR	SENT4	I-Estructura_Corporal	-
15	en	en	SPS00	C1720294#C0332285	calificador#atributo	553-555	100_QUEST_clinical_caseMIR	SENT4	-	-
16	el	el	DA0MS0	-	-	556-558	100_QUEST_clinical_caseMIR	SENT4	-	-
17	que	que	PR0CN000	-	-	559-562	100_QUEST_clinical_caseMIR	SENT4	-	-
18	se	se	P00CN000	-	-	563-565	100_QUEST_clinical_caseMIR	SENT4	-	-
19	observa	observar	VMIP3S0	-	-	566-573	100_QUEST_clinical_caseMIR	SENT4	-	-
20	infiltración	infiltración	NCFS000	C0702249#C0332448	procedimiento#anomalía_morfológica	574-586	100_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
21	masiva	masivo	AQ0FS0	C0522501	calificador	587-593	100_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
22	por	por	SPS00	C0678226	atributo	594-597	100_QUEST_clinical_caseMIR	SENT4	-	-
23	elementos	elemento	NCMP000	C0013879	sustancia	598-607	100_QUEST_clinical_caseMIR	SENT4	-	-
24	inmaduros	inmaduro	AQ0MP0	C0205252	calificador	608-617	100_QUEST_clinical_caseMIR	SENT4	-	-
25	de	de	SPS00	C0332285	atributo	618-620	100_QUEST_clinical_caseMIR	SENT4	-	-
26	núcleo	núcleo	NCMS000	C0007610#C0444669	estructura_celular#calificador	621-627	100_QUEST_clinical_caseMIR	SENT4	-	-
27	hendido	hender	VMP00SM	-	-	628-635	100_QUEST_clinical_caseMIR	SENT4	-	-
28	y	y	CC	C1706368	calificador	636-637	100_QUEST_clinical_caseMIR	SENT4	-	-
29	bastones	bastón	NCMP000	C0006856	objeto_físico	638-646	100_QUEST_clinical_caseMIR	SENT4	-	-
30	de	de	SPS00	C0332285	atributo	647-649	100_QUEST_clinical_caseMIR	SENT4	-	-
31	Auer	auer	NCMS000	-	-	650-654	100_QUEST_clinical_caseMIR	SENT4	-	-
32	en	en	SPS00	C1720294#C0332285	calificador#atributo	655-657	100_QUEST_clinical_caseMIR	SENT4	-	-
33	el	el	DA0MS0	-	-	658-660	100_QUEST_clinical_caseMIR	SENT4	-	-
34	citoplasma	citoplasma	NCMS000	C1383501#C0010834#C0175996	estructura_corporal	661-671	100_QUEST_clinical_caseMIR	SENT4	-	-
35	.	.	Fp	-	-	671-672	100_QUEST_clinical_caseMIR	SENT4	-	-

1	¿	¿	Fia	-	-	673-674	100_QUEST_clinical_caseMIR	SENT5	-	-
2	Cuál	cuál	PT0CS000	-	-	674-678	100_QUEST_clinical_caseMIR	SENT5	-	-
3	es	ser	VSIP3S0	-	-	679-681	100_QUEST_clinical_caseMIR	SENT5	-	-
4	el	el	DA0MS0	-	-	682-684	100_QUEST_clinical_caseMIR	SENT5	-	-
5	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	685-696	100_QUEST_clinical_caseMIR	SENT5	-	-
6	más	más	RG	C0205172	calificador	697-700	100_QUEST_clinical_caseMIR	SENT5	-	-
7	probable	probable	AQ0CS0	C0332148	calificador	701-709	100_QUEST_clinical_caseMIR	SENT5	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	710-712	100_QUEST_clinical_caseMIR	SENT5	-	-
9	este	este	DD0MS0	-	-	713-717	100_QUEST_clinical_caseMIR	SENT5	-	-
10	paciente	paciente	NCCS000	C0030705	persona	718-726	100_QUEST_clinical_caseMIR	SENT5	-	-
11	?	?	Fit	-	-	726-727	100_QUEST_clinical_caseMIR	SENT5	-	-
12	.	.	Fp	-	-	727-728	100_QUEST_clinical_caseMIR	SENT5	-	-

